QuidelOrtho (QDEL) Change in Account Payables (2021 - 2026)
QuidelOrtho (QDEL) reported Change in Account Payables of -$27.7 million for Q1 2026, down 2030.77% on a YoY basis from $1.4 million in Q1 2025, and down 149.55% sequentially from $55.9 million in Q4 2025.
QuidelOrtho (QDEL) Change in Account Payables (2021 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 6 years of Change in Account Payables data on file, last reported at -$27.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 2030.77% year-over-year to -$27.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (up 197.14% YoY), and the FY2025 full-year result was $40.0 million, up 270.94% from the prior year.
- Change in Account Payables eased to -$27.7 million in Q1 2026, from $55.9 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $55.9 million in Q4 2025 to a low of -$27.7 million in Q1 2026.
- A 5-year average of $4.8 million and a median of -$1.3 million in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 960.0% in 2025 and slumped 2030.77% in 2026, its largest moves.
- Tracing QDEL's Change in Account Payables over 5 years: stood at $52.6 million in 2022, then sank by 82.32% to $9.3 million in 2023, then plunged by 169.89% to -$6.5 million in 2024, then soared by 960.0% to $55.9 million in 2025, then sank by 149.55% to -$27.7 million in 2026.
- Business Quant data shows QDEL's Change in Account Payables at -$27.7 million in Q1 2026, $55.9 million in Q4 2025, and $7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | -27.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -27.70 Mn |
| Mar 29, 2026 | -27.70 Mn |
| Dec 28, 2025 | 55.90 Mn |
| Dec 28, 2025 | 55.90 Mn |
| Sep 28, 2025 | 7.60 Mn |
| Sep 28, 2025 | 7.60 Mn |
| Jun 29, 2025 | -22.20 Mn |
| Jun 29, 2025 | -22.20 Mn |
| Mar 30, 2025 | -1.30 Mn |
| Mar 30, 2025 | -1.30 Mn |
| Dec 29, 2024 | -6.50 Mn |
| Dec 29, 2024 | -6.50 Mn |
| Sep 29, 2024 | 7.00 Mn |
| Sep 29, 2024 | 7.00 Mn |
| Jun 30, 2024 | -13.20 Mn |
| Jun 30, 2024 | -13.20 Mn |
| Mar 31, 2024 | -10.70 Mn |
| Mar 31, 2024 | -10.70 Mn |
| Dec 31, 2023 | 9.30 Mn |
| Dec 31, 2023 | 9.30 Mn |